As a result, the abnormal activation of BTK can lead to several B-cell malignancies, including various types of leukemias and lymphomas (16), as well as autoimmune disorders such as rheumatoid arthritis (RA) and multiple sclerosis (MS) (17). Here, BTK is linked to myeloid sarcoma.